medicare weight loss drugs

News

Medicare, drugs

Trump Administration Plan Signals Shift Toward Weight-Loss Drug Coverage For Medicare Patients

The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy under Medicare and Medicaid programs.

Reuters on MSN · 2d

US plans to test Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services.

Yahoo · 2d

Medicaid, Medicare may cover weight loss drugs under new pilot program: report

Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach for many obese Americans.

2don MSN

A Medicare experiment could change who gets Ozempic

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

2don MSN

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

Business Insider2y

Medicare is prohibited from covering weight-loss drugs — Ozempic ...

Medicare has been prohibited from paying for weight-loss medications since 2003, when a law put weight-loss drugs in a category alongside treatments for hair loss, fertility, and ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results